Gelteq Limited Ordinary Shares (GELS) Stock Analysis
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Track GELS in your portfolio for free · Portfolio tracker
What Gelteq Limited Ordinary Shares does
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Key metrics
ETFs linked to GELS
Broad-market and Healthcare sector ETFs an investor holding Gelteq Limited Ordinary Shares is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how GELS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze GELS in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Gelteq Limited Ordinary Shares?
- Gelteq Limited Ordinary Shares trades under the ticker GELS on NASDAQ.
- Which exchange is GELS listed on?
- GELS is listed on NASDAQ.
- What sector does Gelteq Limited Ordinary Shares operate in?
- Gelteq Limited Ordinary Shares is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
- How can PortView help analyze GELS in a portfolio?
- PortView shows GELS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.